This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Shandong Luye Pharmaceutical Co., Ltd.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Wei Sun - Innovator in Pharmaceutical Compositions
Introduction
Wei Sun is a notable inventor based in Yantai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release microspheres. His innovative work has the potential to enhance drug delivery systems and improve patient outcomes.
Latest Patents
Wei Sun holds 1 patent for his invention titled "Pharmaceutical compositions of goserelin sustained release microspheres." This patent describes a composition that includes goserelin, at least one poly (lactide-co-glycolide), and poloxamer or PEG. The sustained release microspheres developed by Wei Sun exhibit comparatively high bioavailability, which promotes the drug's full effect and achieves an entrapment efficiency of over 90%.
Career Highlights
Wei Sun is currently employed at Shandong Luye Pharmaceutical Co., Ltd. His work at this esteemed company has allowed him to focus on innovative drug delivery systems that can significantly impact the pharmaceutical industry. His dedication to research and development has positioned him as a key player in his field.
Collaborations
Wei Sun has collaborated with several talented individuals in his career, including Xuemei Zhang and Tao Wang. These collaborations have fostered a creative environment that encourages innovation and the advancement of pharmaceutical technologies.
Conclusion
Wei Sun's contributions to the field of pharmaceuticals, particularly through his patent on goserelin sustained release microspheres, highlight his role as an influential inventor. His work continues to pave the way for advancements in drug delivery systems, ultimately benefiting patients worldwide.